Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Human IL2 (Iv0020)

Catalog #:   VHF36801 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, Neutralization
Accession: P60568
Overview

Catalog No.

VHF36801

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Target

IL2, IL-2, Aldesleukin, Interleukin-2, TCGF, T-cell growth factor

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P60568

Applications

ELISA, FCM, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0020

Data Image
  • Bioactivity
    Detects IL2 in indirect ELISAs.
  • Flow-cytometry
    Flow-cytometry using anti-human IL2 antibody.THP-1 cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IL2 antibody monoclonal antibody (Catalog # VHF36801 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-mouse antibody (Catalog # PMB96441) and cells analysed on a NovoCyte Flow Cytometer.
References

Gut Microbiota-Derived Butyric Acid Alleviates Glucocorticoid-Associated Osteonecrosis of the Femoral Head via Modulating Inflammatory Cytokines in Bone Marrow Mesenchymal Stem Cells., PMID:40510588

Comparative efficacy of Naringenin and Sinomenine in facilitating the differentiation of mouse hematopoietic stem cells into immature dendritic cells to promote transplantation immunological regulation., PMID:40499621

Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response., PMID:40494938

Characterization and biological evaluation of melatonin-loaded silk fibroin-hyaluronic acid films for multifunctional wound dressings., PMID:40494453

Growth of human regulatory CD4+ T cells is more tightly controlled than effector T cells due to distinctive molecular programming., PMID:40491491

Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune response., PMID:40483876

Spatially Tuned Localization of Interleukins and OX40 Agonists Enhances Synergistic Anti-Tumor Immunity., PMID:40475557

New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines., PMID:40470197

Effect of statins on IL-10 signaling and production by chronic lymphocytic leukemia cells., PMID:40456521

Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models., PMID:40425532

Health-related effects of byproducts from the food industry within in vivo models: a systematic review., PMID:40400178

Synergistic anti-tumor effects of mRNA vaccine and PERK inhibitor combination in melanoma treatment., PMID:40383023

The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocompetent Model., PMID:40361460

Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors., PMID:40361381

A Colombian strain of Clostridioides difficile ribotype 002 induces a highly inflammatory response in a mouse infection model., PMID:40355394

Luminescent mouse model of endometriosis: three-dimensional morphology of lesions and cytokine profiles., PMID:40350305

Tilianin regulates the proliferation, invasion and tumor immune microenvironment of thyroid cancer cells through the TLR4/NF-κB axis., PMID:40349407

Leafing a mark on immunity: Quercetin-3-O-D-glucopyranoside and quercetin-3-O-(2″,6″-digalloyl)-β-D-galactopyranoside-rich Melia azedarach L. extract's immunoinflammatory effects on an sRBC-immunized BALB/c model., PMID:40345340

HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses., PMID:40343532

Generating potent and persistent antitumor immunity via affinity-tuned CAR-T cells targeting mesothelin., PMID:40341217

Development of a nano-vaccine for high-grade serous ovarian cancer., PMID:40338561

KIF22 promotes the proliferation and immune escape of endometrial cancer cells by activating the STAT3/PDL1 pathway., PMID:40326230

4-Octyl Itaconate Modulates Dendritic Cells Function and Tumor Immunity via NRF2 Activation., PMID:40322530

The effect of heat-inactivated BBMN68 on immune regulation and gut microbiota in immunosuppressed mice and exploration of its immunomodulation postbiotic functional components., PMID:40316116

Regulatory T cells suppress GM-CSF-producing T helper cells via IL-2 modulation to restrain immunopathology., PMID:40315053

Immunomodulatory potential of phosphorus: insights from experimental mice models under normal and immunosuppressive condition., PMID:40294527

Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine., PMID:40292218

IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15., PMID:40285351

Bioinformatics analysis reveals CTSF suppresses tumor cell malignant phenotype and CD8 + T cell exhaustion by downregulating Bcl- 2 protein in the microenvironment of bladder cancer., PMID:40278892

IL-10 alleviates aTCMR by inhibiting NFATc1 signaling pathway of T cells after kidney transplantation., PMID:40268206

Exploring the mechanism of esculetin extracted from Chroogomphus rutilus in treating liver cancer based on network pharmacology, molecular docking, and in vivo experimental validation., PMID:40254108

Effect of physical modification on the immunomodulatory activity of carboxymethyl pachymaran., PMID:40253046

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial., PMID:40251644

Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v., PMID:40250867

Amuc_1434 From Akkermansia muciniphila Enhances CD8+ T Cell-Mediated Anti-Tumor Immunity by Suppressing PD-L1 in Colorectal Cancer., PMID:40231387

The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate., PMID:40227411

Design of a peptide-based vaccine against human respiratory syncytial virus using a reverse vaccinology approach: evaluation of immunogenicity, antigenicity, allergenicity, and toxicity., PMID:40226615

Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects., PMID:40216443

Breaking the scar barrier: The anti-fibrotic and hemodynamic benefits of total salvianolic acid in hypertrophic scars., PMID:40216314

Discovery of novel JAK3 inhibitors for the treatment of atopic dermatitis., PMID:40216205

Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities., PMID:40199011

Revolutionizing Chikungunya Vaccines: mRNA Breakthroughs With Molecular and Immune Simulations., PMID:40182080

[Identification of genes regulating human CAR-T cell proliferation by genome-wide CRISPR screening]., PMID:40175136

CD45-mediated apoptosis and IL-2 receptor downregulation by serine proteases secreted from diarrheagenic bacteria., PMID:40166318

Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles., PMID:40154979

Self-luminous nanoengineered bacteria with the sustained release of interleukin 2 as an in situ vaccine for enhanced cancer immunotherapy., PMID:40154768

Anti-CD137 agonist antibody-independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma., PMID:40145091

Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies., PMID:40132909

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs., PMID:40125432

Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors., PMID:40120499

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Human IL2 (Iv0020) [VHF36801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only